Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nada Abla
Observed name:
Abla, Nada
Institution:
Medicines for Malaria Venture
Observed institutions:
University of Geneva,
Merck KGaA, Darmstadt (Germany),
University of California, San Francisco,
Merck Serono S.A. (Switzerland),
Simcyp (United Kingdom),
Merck Healthcare KGaA, Darmstadt (Germany),
Medicines for Malaria Venture,
University of Lausanne
show all 8
ORCID:
0000-0002-5912-744X
Observed ORCID:
0000-0002-5912-744X
OpenAlex ID:
A5085709140
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond
2016
·
Wesley C. Van Voorhis
, John H. Adams
, et al.
·
PLoS Pathogens
·
435
PDF
An in vitro toolbox to accelerate anti-malarial drug discovery and development
2020
·
Susan A. Charman
, Alice Andreu
, et al.
·
Malaria Journal
·
149
PDF
The Human Multidrug Resistance Protein 4 (MRP4, ABCC4): Functional Analysis of a Highly Polymorphic Gene
2008
·
Nada Abla
, Leslie W. Chinn
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
121
Effect of Charge and Molecular Weight on Transdermal Peptide Delivery by Iontophoresis
2005
·
Nada Abla
, Aarti Naik
, et al.
·
Pharmaceutical Research
·
55
Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model
2017
·
Nada Abla
, Jennifer Keiser
, et al.
·
PLoS neglected tropical diseases
·
51
PDF
Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin
2005
·
Nada Abla
, Aarti Naik
, et al.
·
Journal of Controlled Release
·
50
Identification and Optimization of an Aminoalcohol-Carbazole Series with Antimalarial Properties
2013
·
Jérôme Molette
, Julie Routier
, et al.
·
ACS Medicinal Chemistry Letters
·
43
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183
2022
·
Laura E. de Vries
, Patrick A. M. Jansen
, et al.
·
Nature Communications
·
42
PDF
Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies
2014
·
Philipp Haselmayer
, Montserrat Camps
, et al.
·
Frontiers in Immunology
·
39
PDF
Discovery of Potent, Selective, and Orally Bioavailable Alkynylphenoxyacetic Acid CRTH2 (DP2) Receptor Antagonists for the Treatment of Allergic Inflammatory Diseases
2011
·
Stefano Crosignani
, Adeline Prêtre
, et al.
·
Journal of Medicinal Chemistry
·
34
Topical Iontophoresis of Valaciclovir Hydrochloride Improves Cutaneous Aciclovir Delivery
2006
·
Nada Abla
, Aarti Naik
, et al.
·
Pharmaceutical Research
·
27
Using Human Plasma as an Assay Medium in Caco-2 Studies Improves Mass Balance for Lipophilic Compounds
2018
·
Kasiram Katneni
, Thao Pham
, et al.
·
Pharmaceutical Research
·
25
PDF
Extrapolation of praziquantel pharmacokinetics to a pediatric population: a cautionary tale
2018
·
Peter L. Bonate
, Tianli Wang
, et al.
·
Journal of Pharmacokinetics and Pharmacodynamics
·
24
PDF
Development and application of a PBPK modeling strategy to support antimalarial drug development
2023
·
Nada Abla
, Eleanor Howgate
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
21
PDF
Capillary zone electrophoresis for the estimation of transdermal iontophoretic mobility
2005
·
Nada Abla
, Laurent Geiser
, et al.
·
Journal of Pharmaceutical Sciences
·
19
Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial
2022
·
Nomathemba Chandiwana
, Chelsea Kruger
, et al.
·
EBioMedicine
·
18
PDF
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Coadministered Ruxolitinib and Artemether-Lumefantrine in Healthy Adults
2021
·
M. Farouk Chughlay
, Karen I. Barnes
, et al.
·
Antimicrobial Agents and Chemotherapy
·
17
Long-Lasting and Fast-Acting in Vivo Efficacious Antiplasmodial Azepanylcarbazole Amino Alcohol
2017
·
Nada Abla
, Sridevi Bashyam
, et al.
·
ACS Medicinal Chemistry Letters
·
14
Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic Acids
2011
·
Stefano Crosignani
, Catherine Jorand-Lebrun
, et al.
·
ACS Medicinal Chemistry Letters
·
14
A fast screening strategy for characterizing peptide delivery by transdermal iontophoresis
2009
·
Yveline Henchoz
, Nada Abla
, et al.
·
Journal of Controlled Release
·
14
PBPK ‐Led Assessment of Antimalarial Drug Concentrations in Breastmilk: A Strategy for Optimal Use of Prediction Methods to Guide Decision Making in an Understudied Population
2025
·
Lisa M. Almond
, Khaled Abduljalil
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
8
PDF
An innovative study design with intermittent dosing to generate a GLP-regulatory package in preclinical species for long lasting molecule M5717, inhibitor of Plasmodium eukaryotic translation elongation factor 2
2022
·
Philip Hewitt
, Nada Abla
, et al.
·
Toxicology and Applied Pharmacology
·
8
PDF
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure
2024
·
Nada Abla
, Anne Claire Marrast
, et al.
·
Malaria Journal
·
7
PDF
Insights into Praziquantel Metabolism and Potential Enantiomeric Cytochrome P450–Mediated Drug-Drug Interaction
2020
·
Gloria Vendrell-Navarro
, Holger Scheible
, et al.
·
Drug Metabolism and Disposition
·
7
PDF
Cytochrome P450-Mediated Metabolism and CYP Inhibition for the Synthetic Peroxide Antimalarial OZ439
2021
·
David M. Shackleford
, Francis C. K. Chiu
, et al.
·
ACS Infectious Diseases
·
6
Show more works
View as search
Works count:
53
Citation count:
1,275
H-index:
17
I10-index:
20
Year
Topic
Type